Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 125 entries
Sorted by: Best Match Show Resources per page
New insights into the origin of unstable sodium graphite intercalation compounds.

Physical chemistry chemical physics : PCCP

Lenchuk O, Adelhelm P, Mollenhauer D.
PMID: 31455956
Phys Chem Chem Phys. 2019 Sep 21;21(35):19378-19390. doi: 10.1039/c9cp03453f. Epub 2019 Aug 28.

The thermodynamically unstable binary graphite intercalation compounds (GICs) with Na remain a main drawback preventing the implementation of Na-ion batteries in the market. In order to shed some light on the origin of Na-GICs instability, we investigate the structure...

Cite
Lenchuk O, Adelhelm P, Mollenhauer D. New insights into the origin of unstable sodium graphite intercalation compounds. Phys Chem Chem Phys. 2019;21(35):19378-19390doi: 10.1039/c9cp03453f.
Lenchuk, O., Adelhelm, P., & Mollenhauer, D. (2019). New insights into the origin of unstable sodium graphite intercalation compounds. Physical chemistry chemical physics : PCCP, 21(35), 19378-19390. https://doi.org/10.1039/c9cp03453f
Lenchuk, Olena, et al. "New insights into the origin of unstable sodium graphite intercalation compounds." Physical chemistry chemical physics : PCCP vol. 21,35 (2019): 19378-19390. doi: https://doi.org/10.1039/c9cp03453f
Lenchuk O, Adelhelm P, Mollenhauer D. New insights into the origin of unstable sodium graphite intercalation compounds. Phys Chem Chem Phys. 2019 Sep 21;21(35):19378-19390. doi: 10.1039/c9cp03453f. Epub 2019 Aug 28. PMID: 31455956.
Copy Download .nbib Format: NLM
Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

Nature

Lodygin D, Hermann M, Schweingruber N, Flügel-Koch C, Watanabe T, Schlosser C, Merlini A, Körner H, Chang HF, Fischer HJ, Reichardt HM, Zagrebelsky M, Mollenhauer B, Kügler S, Fitzner D, Frahm J, Stadelmann C, Haberl M, Odoardi F, Flügel A.
PMID: 30867589
Nature. 2019 Mar;567(7749):E15. doi: 10.1038/s41586-019-1047-0.

In this Article, owing to an error during the production process, the y-axis label of Fig. 2c should read "Number of T

Cite
Lodygin D, Hermann M, Schweingruber N, et al. Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;567(7749):E15doi: 10.1038/s41586-019-1047-0.
Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H. F., Fischer, H. J., Reichardt, H. M., Zagrebelsky, M., Mollenhauer, B., Kügler, S., Fitzner, D., Frahm, J., Stadelmann, C., Haberl, M., Odoardi, F., & Flügel, A. (2019). Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature, 567(7749), E15. https://doi.org/10.1038/s41586-019-1047-0
Lodygin, Dmitri, et al. "Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration." Nature vol. 567,7749 (2019): E15. doi: https://doi.org/10.1038/s41586-019-1047-0
Lodygin D, Hermann M, Schweingruber N, Flügel-Koch C, Watanabe T, Schlosser C, Merlini A, Körner H, Chang HF, Fischer HJ, Reichardt HM, Zagrebelsky M, Mollenhauer B, Kügler S, Fitzner D, Frahm J, Stadelmann C, Haberl M, Odoardi F, Flügel A. Publisher Correction: β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019 Mar;567(7749):E15. doi: 10.1038/s41586-019-1047-0. PMID: 30867589.
Copy Download .nbib Format: NLM
Adsorption of Mono- and Divalent 4-(Dimethylamino)pyridines on Gold Surfaces: Studies by Surface-Enhanced Raman Scattering and Density Functional Theory.

Langmuir : the ACS journal of surfaces and colloids

Gong X, Taszarek M, Schefzig L, Reissig HU, Thierbach S, Wassermann B, Graf C, Mollenhauer D, Rühl E.
PMID: 31173693
Langmuir. 2019 Jul 02;35(26):8667-8680. doi: 10.1021/acs.langmuir.9b00371. Epub 2019 Jun 20.

The adsorption thermodynamics of 4-(dimethylamino)pyridine (DMAP) and its five divalent derivatives di-DMAP- n (2 ≤ n ≤ 6) with gradually increasing methylene-spacer lengths n binding to planar gold surfaces has been studied by surface-enhanced Raman spectroscopy (SERS) and density...

Cite
Gong X, Taszarek M, Schefzig L, et al. Adsorption of Mono- and Divalent 4-(Dimethylamino)pyridines on Gold Surfaces: Studies by Surface-Enhanced Raman Scattering and Density Functional Theory. Langmuir. 2019;35(26):8667-8680doi: 10.1021/acs.langmuir.9b00371.
Gong, X., Taszarek, M., Schefzig, L., Reissig, H. U., Thierbach, S., Wassermann, B., Graf, C., Mollenhauer, D., & Rühl, E. (2019). Adsorption of Mono- and Divalent 4-(Dimethylamino)pyridines on Gold Surfaces: Studies by Surface-Enhanced Raman Scattering and Density Functional Theory. Langmuir : the ACS journal of surfaces and colloids, 35(26), 8667-8680. https://doi.org/10.1021/acs.langmuir.9b00371
Gong, Xin, et al. "Adsorption of Mono- and Divalent 4-(Dimethylamino)pyridines on Gold Surfaces: Studies by Surface-Enhanced Raman Scattering and Density Functional Theory." Langmuir : the ACS journal of surfaces and colloids vol. 35,26 (2019): 8667-8680. doi: https://doi.org/10.1021/acs.langmuir.9b00371
Gong X, Taszarek M, Schefzig L, Reissig HU, Thierbach S, Wassermann B, Graf C, Mollenhauer D, Rühl E. Adsorption of Mono- and Divalent 4-(Dimethylamino)pyridines on Gold Surfaces: Studies by Surface-Enhanced Raman Scattering and Density Functional Theory. Langmuir. 2019 Jul 02;35(26):8667-8680. doi: 10.1021/acs.langmuir.9b00371. Epub 2019 Jun 20. PMID: 31173693.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Aug 07; doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, . https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. (2021). doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Aug 07; doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Frontiers in neurology

Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A.
PMID: 34659081
Front Neurol. 2021 Oct 01;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021.

No abstract available.

Cite
Pagano G, Boess FG, Taylor KI, et al. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021;12:705407doi: 10.3389/fneur.2021.705407.
Pagano, G., Boess, F. G., Taylor, K. I., Ricci, B., Mollenhauer, B., Poewe, W., Boulay, A., Anzures-Cabrera, J., Vogt, A., Marchesi, M., Post, A., Nikolcheva, T., Kinney, G. G., Zago, W. M., Ness, D. K., Svoboda, H., Britschgi, M., Ostrowitzki, S., Simuni, T., Marek, K., Koller, M., Sevigny, J., Doody, R., Fontoura, P., Umbricht, D., Bonni, A. (2021). A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in neurology, 12705407. https://doi.org/10.3389/fneur.2021.705407
Pagano, Gennaro, et al. "A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data." Frontiers in neurology vol. 12 (2021): 705407. doi: https://doi.org/10.3389/fneur.2021.705407
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Front Neurol. 2021 Oct 01;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. PMID: 34659081; PMCID: PMC8518716.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;36(12):2874-2887doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, 36(12), 2874-2887. https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. 36,12 (2021): 2874-2887. doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.

Parkinsonism & related disorders

Lillig R, Ophey A, Schulz JB, Reetz K, Wojtala J, Storch A, Liepelt-Scarfone I, Becker S, Berg D, Balzer-Geldsetzer M, Kassubek J, Hilker-Roggendorf R, Witt K, Mollenhauer B, Trenkwalder C, Roeske S, Wittchen HU, Riedel O, Dodel R, Kalbe E.
PMID: 34418761
Parkinsonism Relat Disord. 2021 Sep;90:90-97. doi: 10.1016/j.parkreldis.2021.07.034. Epub 2021 Aug 04.

INTRODUCTION: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) is a renowned cognitive test battery, which has been extended in its German version to the CERAD-Plus including tests of executive functions and processing speed. The most commonly...

Cite
Lillig R, Ophey A, Schulz JB, et al. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Parkinsonism Relat Disord. 2021;90:90-97doi: 10.1016/j.parkreldis.2021.07.034.
Lillig, R., Ophey, A., Schulz, J. B., Reetz, K., Wojtala, J., Storch, A., Liepelt-Scarfone, I., Becker, S., Berg, D., Balzer-Geldsetzer, M., Kassubek, J., Hilker-Roggendorf, R., Witt, K., Mollenhauer, B., Trenkwalder, C., Roeske, S., Wittchen, H. U., Riedel, O., Dodel, R., & Kalbe, E. (2021). A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Parkinsonism & related disorders, 9090-97. https://doi.org/10.1016/j.parkreldis.2021.07.034
Lillig, Robert, et al. "A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study." Parkinsonism & related disorders vol. 90 (2021): 90-97. doi: https://doi.org/10.1016/j.parkreldis.2021.07.034
Lillig R, Ophey A, Schulz JB, Reetz K, Wojtala J, Storch A, Liepelt-Scarfone I, Becker S, Berg D, Balzer-Geldsetzer M, Kassubek J, Hilker-Roggendorf R, Witt K, Mollenhauer B, Trenkwalder C, Roeske S, Wittchen HU, Riedel O, Dodel R, Kalbe E. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Parkinsonism Relat Disord. 2021 Sep;90:90-97. doi: 10.1016/j.parkreldis.2021.07.034. Epub 2021 Aug 04. PMID: 34418761.
Copy Download .nbib Format: NLM
Seasonal nitrogen fluxes of the Lena River Delta.

Ambio

Sanders T, Fiencke C, Fuchs M, Haugk C, Juhls B, Mollenhauer G, Ogneva O, Overduin P, Palmtag J, Povazhniy V, Strauss J, Tuerena R, Zell N, Dähnke K.
PMID: 34914031
Ambio. 2021 Dec 16; doi: 10.1007/s13280-021-01665-0. Epub 2021 Dec 16.

The Arctic is nutrient limited, particularly by nitrogen, and is impacted by anthropogenic global warming which occurs approximately twice as fast compared to the global average. Arctic warming intensifies thawing of permafrost-affected soils releasing their large organic nitrogen reservoir....

Cite
Sanders T, Fiencke C, Fuchs M, et al. Seasonal nitrogen fluxes of the Lena River Delta. Ambio. 2021;doi: 10.1007/s13280-021-01665-0.
Sanders, T., Fiencke, C., Fuchs, M., Haugk, C., Juhls, B., Mollenhauer, G., Ogneva, O., Overduin, P., Palmtag, J., Povazhniy, V., Strauss, J., Tuerena, R., Zell, N., & Dähnke, K. (2021). Seasonal nitrogen fluxes of the Lena River Delta. Ambio, . https://doi.org/10.1007/s13280-021-01665-0
Sanders, Tina, et al. "Seasonal nitrogen fluxes of the Lena River Delta." Ambio vol. (2021). doi: https://doi.org/10.1007/s13280-021-01665-0
Sanders T, Fiencke C, Fuchs M, Haugk C, Juhls B, Mollenhauer G, Ogneva O, Overduin P, Palmtag J, Povazhniy V, Strauss J, Tuerena R, Zell N, Dähnke K. Seasonal nitrogen fluxes of the Lena River Delta. Ambio. 2021 Dec 16; doi: 10.1007/s13280-021-01665-0. Epub 2021 Dec 16. PMID: 34914031.
Copy Download .nbib Format: NLM
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders.

Movement disorders : official journal of the Movement Disorder Society

Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B.
PMID: 34363416
Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07.

BACKGROUND: Objective diagnostic biomarkers are needed to support a clinical diagnosis.OBJECTIVES: To analyze markers in various neurodegenerative disorders to identify diagnostic biomarker candidates for mainly α-synuclein (aSyn)-related disorders (ASRD) in serum and/or cerebrospinal fluid (CSF).METHODS: Upon initial testing of...

Cite
Schulz I, Kruse N, Gera RG, et al. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021;36(12):2874-2887doi: 10.1002/mds.28738.
Schulz, I., Kruse, N., Gera, R. G., Kremer, T., Cedarbaum, J., Barbour, R., Zago, W., Schade, S., Otte, B., Bartl, M., Hutten, S. J., Trenkwalder, C., & Mollenhauer, B. (2021). Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Movement disorders : official journal of the Movement Disorder Society, 36(12), 2874-2887. https://doi.org/10.1002/mds.28738
Schulz, Isabel, et al. "Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders." Movement disorders : official journal of the Movement Disorder Society vol. 36,12 (2021): 2874-2887. doi: https://doi.org/10.1002/mds.28738
Schulz I, Kruse N, Gera RG, Kremer T, Cedarbaum J, Barbour R, Zago W, Schade S, Otte B, Bartl M, Hutten SJ, Trenkwalder C, Mollenhauer B. Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders. Mov Disord. 2021 Dec;36(12):2874-2887. doi: 10.1002/mds.28738. Epub 2021 Aug 07. PMID: 34363416.
Copy Download .nbib Format: NLM
Corrigendum: Synthesis of an Iron(IV) Aqua-Oxido Complex Using Ozone as an Oxidant.

Angewandte Chemie (International ed. in English)

Schaub S, Miska A, Becker J, Zahn S, Mollenhauer D, Sakshath S, Schünemann V, Schindler S.
PMID: 30964244
Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5482. doi: 10.1002/anie.201813427. Epub 2018 Dec 20.

No abstract available.

Cite
Schaub S, Miska A, Becker J, et al. Corrigendum: Synthesis of an Iron(IV) Aqua-Oxido Complex Using Ozone as an Oxidant. Angew Chem Int Ed Engl. 2018;58(17):5482doi: 10.1002/anie.201813427.
Schaub, S., Miska, A., Becker, J., Zahn, S., Mollenhauer, D., Sakshath, S., Schünemann, V., & Schindler, S. (2019). Corrigendum: Synthesis of an Iron(IV) Aqua-Oxido Complex Using Ozone as an Oxidant. Angewandte Chemie (International ed. in English), 58(17), 5482. https://doi.org/10.1002/anie.201813427
Schaub, Stefan, et al. "Corrigendum: Synthesis of an Iron(IV) Aqua-Oxido Complex Using Ozone as an Oxidant." Angewandte Chemie (International ed. in English) vol. 58,17 (2019): 5482. doi: https://doi.org/10.1002/anie.201813427
Schaub S, Miska A, Becker J, Zahn S, Mollenhauer D, Sakshath S, Schünemann V, Schindler S. Corrigendum: Synthesis of an Iron(IV) Aqua-Oxido Complex Using Ozone as an Oxidant. Angew Chem Int Ed Engl. 2019 Apr 16;58(17):5482. doi: 10.1002/anie.201813427. Epub 2018 Dec 20. PMID: 30964244.
Copy Download .nbib Format: NLM
Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters.

Angewandte Chemie (International ed. in English)

Hanau K, Schwan S, Schäfer MR, Müller MJ, Dues C, Rinn N, Sanna S, Chatterjee S, Mollenhauer D, Dehnen S.
PMID: 33006797
Angew Chem Int Ed Engl. 2021 Jan 18;60(3):1176-1186. doi: 10.1002/anie.202011370. Epub 2020 Dec 15.

We report the extension of the class of organotetrel sulfide clusters with further examples of the still rare silicon-based species, synthesized from RSiCl

Cite
Hanau K, Schwan S, Schäfer MR, et al. Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters. Angew Chem Int Ed Engl. 2020;60(3):1176-1186doi: 10.1002/anie.202011370.
Hanau, K., Schwan, S., Schäfer, M. R., Müller, M. J., Dues, C., Rinn, N., Sanna, S., Chatterjee, S., Mollenhauer, D., & Dehnen, S. (2021). Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters. Angewandte Chemie (International ed. in English), 60(3), 1176-1186. https://doi.org/10.1002/anie.202011370
Hanau, Katharina, et al. "Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters." Angewandte Chemie (International ed. in English) vol. 60,3 (2021): 1176-1186. doi: https://doi.org/10.1002/anie.202011370
Hanau K, Schwan S, Schäfer MR, Müller MJ, Dues C, Rinn N, Sanna S, Chatterjee S, Mollenhauer D, Dehnen S. Towards Understanding the Reactivity and Optical Properties of Organosilicon Sulfide Clusters. Angew Chem Int Ed Engl. 2021 Jan 18;60(3):1176-1186. doi: 10.1002/anie.202011370. Epub 2020 Dec 15. PMID: 33006797; PMCID: PMC7839700.
Copy Download .nbib Format: NLM
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients.

NPJ Parkinson's disease

Baldelli L, Schade S, Jesús S, Schreglmann SR, Sambati L, Gómez-Garre P, Halsband C, Calandra-Buonaura G, Adarmes-Gómez AD, Sixel-Döring F, Zenesini C, Pirazzini C, Garagnani P, Bacalini MG, Bhatia KP, Cortelli P, Mollenhauer B, Franceschi C, Mir P, Trenkwalder C, Provini F.
PMID: 34493736
NPJ Parkinsons Dis. 2021 Sep 07;7(1):78. doi: 10.1038/s41531-021-00219-1.

A prodromal phase of Parkinson's disease (PD) may precede motor manifestations by decades. PD patients' siblings are at higher risk for PD, but the prevalence and distribution of prodromal symptoms are unknown. The study objectives were (1) to assess...

Cite
Baldelli L, Schade S, Jesús S, et al. Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients. NPJ Parkinsons Dis. 2021;7(1):78doi: 10.1038/s41531-021-00219-1.
Baldelli, L., Schade, S., Jesús, S., Schreglmann, S. R., Sambati, L., Gómez-Garre, P., Halsband, C., Calandra-Buonaura, G., Adarmes-Gómez, A. D., Sixel-Döring, F., Zenesini, C., Pirazzini, C., Garagnani, P., Bacalini, M. G., Bhatia, K. P., Cortelli, P., Mollenhauer, B., Franceschi, C., Mir, P., Trenkwalder, C., & Provini, F. (2021). Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients. NPJ Parkinson's disease, 7(1), 78. https://doi.org/10.1038/s41531-021-00219-1
Baldelli, Luca, et al. "Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients." NPJ Parkinson's disease vol. 7,1 (2021): 78. doi: https://doi.org/10.1038/s41531-021-00219-1
Baldelli L, Schade S, Jesús S, Schreglmann SR, Sambati L, Gómez-Garre P, Halsband C, Calandra-Buonaura G, Adarmes-Gómez AD, Sixel-Döring F, Zenesini C, Pirazzini C, Garagnani P, Bacalini MG, Bhatia KP, Cortelli P, Mollenhauer B, Franceschi C, Mir P, Trenkwalder C, Provini F. Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients. NPJ Parkinsons Dis. 2021 Sep 07;7(1):78. doi: 10.1038/s41531-021-00219-1. PMID: 34493736; PMCID: PMC8423761.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 125 entries